Speaker Name: Dr. Nickie Mathew
Session Description:
In the adult population of those using stimulant drugs, such as methamphetamine, there is often a clinical question of how best to diagnose and treat ADHD. Also, concurrent within this population is a large percentage of people who experience psychosis. Given all of these intersecting clinical issues, this talk aims to provide practical guidance in treating this population.
Learning Objective:
- Understand the performance-enhancing nature of stimulant medication
- Understand the process of diagnosing and treating ADHD in those with substance use or psychotic disorders
- Understand the relationship between stimulants and psychosis
- Understand how to treat psychosis in those with stimulant use disorder
References:
Margaret H. Sibley (2021). Empirically-informed guidelines for first-time adult ADHD diagnosis, Journal of Clinical and Experimental Neuropsychology, 43:4, 340-351, DOI: 10.1080/13803395.2021.1923665
Shirai T, Okazaki S, Tanifuji T, Otsuka I, Horai T, Mouri K, Takemura Y, Aso K, Yamamoto N, Hishimoto A. Epigenome-wide association study on methamphetamine dependence. Addict Biol. 2024 Mar;29(3):e13383.
doi: 10.1111/adb.13383
Moran, L. V., Ongur, D., Hsu, J., Castro, V. M., Perlis, R. H., & Schneeweiss, S. (2019). Psychosis with methylphenidate or amphetamine in patients with ADHD. New England Journal of Medicine, 380(12), 1128-1138.
BIO
Dr. Mathew completed an addiction psychiatry fellowship at Yale University and a forensic psychiatry fellowship at the University of British Columbia. He is a Clinical Professor at the University of British Columbia. He is currently serving as the medical director for complex concurrent disorders at the Provincial Health Services Authority.